BIOTRONIK has announced that its latest implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D) that are approved for MRI use have received CE marking and have been already implanted in a first batch of patients. The Inventra series, featuring the company’s Sentus MRI-compatible quadripolar leads, are able to deliver shocks with a more targeted effect.
The new defibs feature MorphMatch technology that reduces shocks by detecting the native morphology, as well as anti-tachycardia pacing (ATP) optimization to keep the heart beating at a healthy rate.
From the announcement:
BIOTRONIK is the first and only company to offer heart failure patients cardiac resynchronization therapy devices and leads that can undergo MRI scans. As patients age, they may develop comorbidities, and MRI scans can be critical in diagnosing conditions like stroke, brain tumors or orthopedic conditions.
BIOTRONIK has included its Closed Loop Stimulation (CLS) technology in ICDs for the first time. CLS helps patients experience the most natural rate adoption possible by utilizing their neurological information. It is the only system that allows pacemakers, and now ICDs, to react naturally to patients’ physical as well as mental activity or stress.
Press release: Physicians Implant World’s First ProMRI® Quadripolar CRT-D…